According to a newly published market research report by 24LifeSciences, global all trans retinoic acid market was valued at USD 520 million in 2025 and is projected to reach USD 780 million by 2034, growing at a compound annual growth rate (CAGR) of 4.7% during the forecast period 2026–2034.
All Trans Retinoic Acid (ATRA), chemically known as tretinoin, is a derivative of vitamin A...
According to a newly published market research report by 24LifeSciences, global all trans retinoic acid market was valued at USD 520 million in 2025 and is projected to reach USD 780 million by 2034, growing at a compound annual growth rate (CAGR) of 4.7% during the forecast period 2026–2034.
All Trans Retinoic Acid (ATRA), chemically known as tretinoin, is a derivative of vitamin A...
According to a newly published market research report by 24LifeSciences, global drugs for brucellosis market was valued at USD 120 million in 2024 and is projected to reach USD 198 million by 2032, growing at a compound annual growth rate (CAGR) of 5.2% during the forecast period 2025–2032.
Brucellosis, a zoonotic infection caused by Brucella species (primarily B. melitensis, B....
According to a newly published market research report by 24LifeSciences, global drugs for brucellosis market was valued at USD 120 million in 2024 and is projected to reach USD 198 million by 2032, growing at a compound annual growth rate (CAGR) of 5.2% during the forecast period 2025–2032.
Brucellosis, a zoonotic infection caused by Brucella species (primarily B. melitensis, B....
According to a newly published market research report by 24LifeSciences, global TB diagnostic market was valued at USD 2.57 billion in 2024 and is projected to reach USD 3.26 billion by 2031, growing at a compound annual growth rate (CAGR) of 3.6% during the forecast period 2025–2031.
Tuberculosis diagnostics encompass various medical tests and procedures including radiographic...
According to a newly published market research report by 24LifeSciences, global TB diagnostic market was valued at USD 2.57 billion in 2024 and is projected to reach USD 3.26 billion by 2031, growing at a compound annual growth rate (CAGR) of 3.6% during the forecast period 2025–2031.
Tuberculosis diagnostics encompass various medical tests and procedures including radiographic...
According to a newly published market research report by 24LifeSciences, global immune checkpoint inhibitors market was valued at USD 42.6 billion in 2023 and is projected to reach USD 98.7 billion by 2032, growing at a compound annual growth rate (CAGR) of 10.7% during the forecast period 2025-2032.
Immune checkpoint inhibitors are monoclonal antibodies that block proteins used by cancer cells...
According to a newly published market research report by 24LifeSciences, global immune checkpoint inhibitors market was valued at USD 42.6 billion in 2023 and is projected to reach USD 98.7 billion by 2032, growing at a compound annual growth rate (CAGR) of 10.7% during the forecast period 2025-2032.
Immune checkpoint inhibitors are monoclonal antibodies that block proteins used by cancer cells...
According to a newly published market research report by 24LifeSciences, global cranial mesh market was valued at USD 472.8 million in 2024 and is projected to reach USD 682.4 million by 2032, growing at a compound annual growth rate (CAGR) of 4.7% during the forecast period 2024–2032.
Cranial mesh, clinically known as cranial reconstruction implants, are critical medical devices...
According to a newly published market research report by 24LifeSciences, global cranial mesh market was valued at USD 472.8 million in 2024 and is projected to reach USD 682.4 million by 2032, growing at a compound annual growth rate (CAGR) of 4.7% during the forecast period 2024–2032.
Cranial mesh, clinically known as cranial reconstruction implants, are critical medical devices...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek